GDF15 and colorectal cancer: The calculated standard deviation of our MS measurements (±79.31 fmol/ml) represents 48.2% of the mean GDF15 serum concentration, which is significantly better than the error produced by our ELISA (108.9%), or the variability in the ELISA of the above mentioned 58 colorectal cancer patients (62.7%).